FOXO4-DRI

FOXO4-DRI (D-Retro-Inverso) is a pioneering peptide designed to selectively target senescent cells by disrupting the interaction between FOXO4 and p53 proteins. This innovative mechanism induces apoptosis in aging cells while preserving healthy cells, offering promising potential in anti-aging research, regenerative medicine, and age-related disease studies. 

• Selective Senolytic Activity: Targets only senescent cells without harming normal cells.
   
• Research-Grade Quality: Synthesized under strict quality control for laboratory and experimental use.
   
• Cellular Health & Longevity: Supports studies aimed at understanding cellular aging and tissue regeneration.
   
• Preclinical Research Applications: Demonstrated efficacy in restoring hormonal balance, improving tissue function, and reducing fibrosis in animal models.

• Anti-aging and longevity studies
   
• Regenerative medicine research
   
• Cellular senescence and apoptosis studies
   
• Preclinical investigations into age-related disorders

• Purity: ≥95% (HPLC)
   
• Form: Lyophilized powder
   
• Storage: -20°C, protect from moisture
   

Explore the Potential of FOXO4-DRI:
FOXO4-DRI represents a next-generation tool for scientists and researchers aiming to combat cellular senescence and advance age-related therapeutics. For bulk inquiries, technical support, or collaborative research opportunities, please contact us.